PMID- 18321872 OWN - NLM STAT- MEDLINE DCOM- 20081222 LR - 20211203 IS - 1460-2199 (Electronic) IS - 1047-3211 (Print) IS - 1047-3211 (Linking) VI - 18 IP - 11 DP - 2008 Nov TI - Dopaminergic modulation of auditory cortex-dependent memory consolidation through mTOR. PG - 2646-58 LID - 10.1093/cercor/bhn026 [doi] AB - Previous studies in the auditory cortex of Mongolian gerbils on discrimination learning of the direction of frequency-modulated tones (FMs) revealed that long-term memory formation involves activation of the dopaminergic system, activity of the protein kinase mammalian target of rapamycin (mTOR), and protein synthesis. This led to the hypothesis that the dopaminergic system might modulate memory formation via regulation of mTOR, which is implicated in translational control. Here, we report that the D1/D5 dopamine receptor agonist SKF-38393 substantially improved gerbils' FM discrimination learning when administered systemically or locally into the auditory cortex shortly before, shortly after, or 1 day before conditioning. Although acquisition performance during initial training was normal, the discrimination of FMs was enhanced during retraining performed hours or days after agonist injection compared with vehicle-injected controls. The D1/D5 receptor antagonist SCH-23390, the mTOR inhibitor rapamycin, and the protein synthesis blocker anisomycin suppressed this effect. By immunohistochemistry, D1 dopamine receptors were identified in the gerbil auditory cortex predominantly in the infragranular layers. Together, these findings suggest that in the gerbil auditory cortex dopaminergic inputs regulate mTOR-mediated, protein synthesis-dependent mechanisms, thus controlling for hours or days the consolidation of memory required for the discrimination of complex auditory stimuli. FAU - Schicknick, Horst AU - Schicknick H AD - Leibniz Institute for Neurobiology, D-39118 Magdeburg, Germany. FAU - Schott, Bjorn H AU - Schott BH FAU - Budinger, Eike AU - Budinger E FAU - Smalla, Karl-Heinz AU - Smalla KH FAU - Riedel, Anett AU - Riedel A FAU - Seidenbecher, Constanze I AU - Seidenbecher CI FAU - Scheich, Henning AU - Scheich H FAU - Gundelfinger, Eckart D AU - Gundelfinger ED FAU - Tischmeyer, Wolfgang AU - Tischmeyer W LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080304 PL - United States TA - Cereb Cortex JT - Cerebral cortex (New York, N.Y. : 1991) JID - 9110718 RN - 0 (Dopamine Agonists) RN - 0 (Dopamine Antagonists) RN - 0 (Immunosuppressive Agents) RN - 0 (Protein Synthesis Inhibitors) RN - 0 (Receptors, Dopamine D1) RN - 67287-49-4 (2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine) RN - 6C74YM2NGI (Anisomycin) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - VTD58H1Z2X (Dopamine) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology MH - Animals MH - Anisomycin/pharmacology MH - Auditory Cortex/*physiology MH - Conditioning, Psychological/drug effects/physiology MH - Discrimination Learning/drug effects/*physiology MH - Dopamine/*metabolism MH - Dopamine Agonists/pharmacology MH - Dopamine Antagonists/pharmacology MH - Gerbillinae MH - Immunohistochemistry MH - Immunosuppressive Agents/pharmacology MH - Male MH - Memory/drug effects/*physiology MH - Protein Kinases/*metabolism MH - Protein Synthesis Inhibitors/pharmacology MH - Receptors, Dopamine D1/agonists/antagonists & inhibitors/metabolism MH - Sirolimus/pharmacology MH - TOR Serine-Threonine Kinases PMC - PMC2567422 EDAT- 2008/03/07 09:00 MHDA- 2008/12/23 09:00 PMCR- 2008/03/04 CRDT- 2008/03/07 09:00 PHST- 2008/03/07 09:00 [pubmed] PHST- 2008/12/23 09:00 [medline] PHST- 2008/03/07 09:00 [entrez] PHST- 2008/03/04 00:00 [pmc-release] AID - bhn026 [pii] AID - 10.1093/cercor/bhn026 [doi] PST - ppublish SO - Cereb Cortex. 2008 Nov;18(11):2646-58. doi: 10.1093/cercor/bhn026. Epub 2008 Mar 4.